PTCommunity News June 2016

CMS Report: Doctors, Hospitals Paid Billions by Drug, Device Makers
New Amphetamine Compound Shows Promise in ADHD Patients
Hacker Sells Health Records From Nearly 10 Million Patients
Consumer Group Urges FDA to Add Warnings About Impulsive Behaviors to Labels on Parkinson’s Drugs
FDA Clears First Test to Detect Genetic Markers for Resistant Bacteria Directly From Clinical Specimens
Portable Test Quickly Detects Zika Virus in Saliva for $2
Galena Biopharma Terminates Phase 3 Trial of Breast Cancer Vaccine
HHS Proposes Changes to Medicare Appeals Process
FDA Advisors Narrowly Back Approval of Empagliflozin (Jardiance) for Cardiovascular Indication
FDA Gives “Thumbs Down” to Oral Testosterone Therapy
Testing for Cancer at Home With Cheap Paper Strips
Multiple Sclerosis Drug Ocrelizumab (Ocrevus) Wins Priority Review
“Smart” Cardiac Patch Could Replace Pacemakers
Biotech Industry Shaken by Supreme Court Ruling
Scientists May Have Found Second “Superbug” Gene in New York Patient
FDA Approves Sofosbuvir/Velpatasvir Combo (Epclusa) for Treatment of Chronic HCV Infection
Regorafenib (Stivarga) Improves Survival in Patients With Unresectable Liver Cancer
Best Meds to Treat Migraine in Emergency Setting
FDA Clears Procalcitonin Assay for Sepsis Patients
Cannabis-Based Epilepsy Drug Epidiolex Meets Main Goal in Late-Stage Trial
Positive Results Reported for Nintedanib (Ofev) in Pulmonary Fibrosis Patients
Diabetes Sniffer Dogs? Chemical in Human Breath Signals Low Blood Glucose Levels
FDA Panel to Vote on Whether Empagliflozin (Jardiance) Cuts Risk of Cardiac Death
New Survey Finds One in Five Patients Shares Unused Opioids
Microbes May Be Linked to Breast Cancer Development
Celecoxib/Amlodipine Combo Simultaneously Treats OA Pain and Hypertension in Phase 3 Study
EndoBarrier Device Fails Safety Assessment in Obese Diabetic Patients
NIH Report: Nonmedical Prescription Opioid Use Doubled in 10 Years
FDA Approves Label Update for Ceftazidime/Avibactam (Avycaz)
Justice Department Announces Largest Takedown of Health Care Scammers
CDC Panel Rejects Nasal Spray Flu Vaccine for 2016–2017 Season
Mobile Phones: A Hospital Infection Risk?
House Republicans Unveil Plan to Replace Affordable Care Act
CMS Report: EHRs Not Mature Enough to Report Clinical Quality Measures Correctly
Tau Vaccine for Alzheimer’s Disease Enters Mid-Stage Trial
Pitavastatin (Livalo) Tops Pravastatin in HIV Study
Study: Generic Diabetes Drug Reduces Liver Disease
Telemedicine Kiosks: The Future of Health Care?
Study: Hospitals Can’t Be Blamed for Many Surgical Readmissions
New Link Found Between Diabetes and Alzheimer’s Disease
FDA Approves Rayaldee (Extended-Release Calcifediol) to Treat Hyperparathyroidism in Chronic Kidney Disease
Experimental Zika Vaccine Begins Human Testing
Task Force Issues Guidelines on Screening for Colorectal Cancer
Lung Cancer Drug Brigatinib Submitted for FDA Review
Positive Results Reported for Triple Combination Therapy in COPD Patients
Survey: Value-Based Reimbursement Will Eclipse FFS by 2020
Theranos Says It Will Share Blood-Test Information in August
Potential Drug Target Identified for Zika and Similar Flaviviruses
Study Finds Statin Drugs Reduce Infection Risk in Stroke Patients
German Scientists Discover Molecular Mechanism of Thalidomide
Natural Molecule Could Help Manage Parkinson’s Disease
American Academy of Pain Management Changes Name
Women's Long Work Hours Linked to Alarming Rise in Cancer, Heart Disease
Antiviral Treatment During Pregnancy Reduces Mother-to-Child Transmission of Hepatitis B
Positive Phase 3 Results Reported for Keytruda in Patients With Advanced NSCLC
Positive Top-Line Results Reported for Orphan Drug CCX168 in Treatment of ANCA-Associated Vasculitis
New Genetic Research Can Significantly Improve Drug Development
Pharmacist Association Calls for Ban on Prescription Drug Advertising
Patient Factors Linked to Hospital Readmissions Following General Surgery
Presurgery Chemotherapy May Make Advanced Ovarian Cancers Responsive to Immunotherapy
Jardiance Slows Kidney Disease Progression in Patients With Diabetes and Established Cardiovascular Disease
WHO Cancer Research Agency Links “Very Hot” Beverages to Esophageal Cancer
As If Zika Wasn’t Enough … “Superbugs” Find a Home at Rio’s Olympic Sites
FDA Rejects Abuse-Deterrent Benzhydrocodone/ Acetaminophen Combo
Teva Suspends Sales of Zecuity Migraine Patch
FDA Accepts Application for Promethazine/ Hydrocodone/ Acetaminophen Painkiller
Chondroitin “Essentially Similar” to Celecoxib in Phase 3 Study
Study: Friends and Relatives Share Painkillers, Fuel Opioid Epidemic
CDC: Zika-Transmitting Mosquitoes Found in Most of U.S.
FDA Approves Oral Cholera Vaccine Vaxchora
Inotuzumab Ozogamicin Scores in Pivotal ALL Study
Adult Seizure Drug Ganaxolone Flops in Late-Stage trial
Pfizer Quietly Raises Drug Prices
FDA Panel Recommends Approval of C. difficile Drug Bezlotoxumab
Triple Combination Therapy in the Works for COPD
Extended-Release Topiramate Wins Tentative Approval for Migraine Prophylaxis in Adults
Study: Acute Myeloid Leukemia Is at Least 11 Different Diseases
Medicare’s Two-Midnight Rule Still Puzzles Providers
Two Years Later, Dallas Hospital Won’t Reveal How Ebola Virus Spread
New Guidelines Offer Six Ways Hospitals Can Stem Opioid Epidemic
FDA Advisors Recommend Approval of Oxycodone/Naltrexone Extended-Release Capsules
Investigational Tat Vaccine Improves Response to HIV Drugs
FDA Advisors Back Approval of Abuse-Resistant Opioid Painkiller
Report: U.S. Prevalence of Obesity Increases Among Women, But Not Among Men
FDA Clears Sleep Device for Insomnia
RA Drug Sirukumab Succeeds in Phase 3 Trial
Safety Alert: Serious Heart Problems Reported With High Doses of Loperamide From Abuse and Misuse
Massachusetts Senate Passes Bill to Penalize Hospitals That Pamper VIP Patients
Study: End-of-Life Cancer Patients Receive Aggressive Treatments Despite Efforts to Curb the Practice
FDA Requests Additional Information on Muscular Dystrophy Drug Eteplirsen
FDA Staff Says Long-Acting Oxycodone (Troxyca ER) Can Be Manipulated for Abuse
MS Drug Opicinumab Misses Primary Endpoint in Mid-Stage Trial
FDA Rejects Emergency Treatment for Severe Allergic Reaction
Florida Stores Help Consumers Bypass Federal Ban on Imported Drugs
Report: Primary Care Physicians and Specialists See Double-Digit Salary Hikes
FDA Approves Hypertension Drug Byvalson (Nebivolol/Valsartan)
Ibrutinib (Imbruvica) Provides Durable Responses in Patients With Leukemia/Lymphoma
AHA Report: Almost All U.S. Hospitals Now Use EHRs
FDA Warns of Burns and Scarring With Zecuity Migraine Patch
Hospitals Reduce Non-ICU Catheter-Associated Infections By 32%
New Study Demonstrates Safety of Belbuca (Buprenorphine) Buccal Film for Chronic Pain
Scientists Discover New Treatment for Invasive Breast Cancer
Report: Rare Adverse Effects Scare Patients Away From Osteoporosis Drugs
FDA Approves First Blood Test to Detect Gene Mutation Associated With Non–Small-Cell Lung Cancer
Extended Survival Reported in Brain Cancer Patients Treated With Viral Gene Therapy
Survey: Most Patients Clueless About Risks of X-Rays for Cancer Diagnosis
Topical Hyperhidrosis Drug Succeeds in Late-Stage Studies
California Hospital Cuts Opioid Prescriptions by Half, Recurring ED Visits by 60%
Duke Scientists Discover New Class of Pain Relievers
No Effect Shown on Exercise Improvement for Bosentan Clinical Trials

You are here

PTCommunity News June 2016